ReviewFrontiers in immunology2026
Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas.
Toshali Pandey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it